Physician

Agnieszka Gliwa, MD

According to 2025 Medicare claims, Agnieszka Gliwa, MD (NPI: 1487649919) practices endocrinology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. Gliwa uses personal NPI as billing NPI and primary practice location at 11222-6577. Gliwa is affiliated with the Community Care of Brooklyn IPA, Inc. (ACO ID: A4723), participating under the MSSP model.

Gliwa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 290 traditional Medicare patients, billed 777 HCPCS/CPT codes, and received $66,829 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,567 prescription claims across 681 beneficiaries totaling $2,367,236 in drug costs, led by Ozempic (Semaglutide). DME data shows 219 claims. Open Payments data shows 32 records totaling $821. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $40,778 to $66,829. Similarly, Part D prescription costs have risen steadily, from $1,322,106 to $2,367,236. For DME billing, reported payments moved sharply higher in recent years, from $7,778 to $43,128.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	202	646	$40,778
2016	174	625	$44,343
2017	170	579	$40,208
2018	335	882	$54,450
2019	397	1,166	$71,276
2020	350	968	$53,045
2021	354	942	$73,552
2022	341	877	$73,451
2023	339	881	$77,781
2024	290	777	$66,829

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	572	10,969	$1,322,106
2016	534	11,066	$1,471,415
2017	486	10,770	$1,477,003
2018	470	10,627	$1,592,158
2019	525	10,219	$1,535,614
2020	572	10,940	$1,953,330
2021	601	10,199	$2,123,544
2022	675	10,057	$2,463,903
2023	667	9,630	$2,746,293
2024	681	9,567	$2,367,236

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	180	563	$10,559
2016	165	494	$5,322
2017	93	320	$3,295
2018	118	321	$4,719
2019	111	372	$3,652
2020	101	402	$8,952
2021	76	294	$15,963
2022	87	319	$24,181
2023	99	324	$26,405
2024	68	219	$40,243

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	46	46	$147
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	13	13	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	214	449	$93
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	12	12	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	103	169	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	340	15,580	$482,983
Jardiance	Empagliflozin	312	19,260	$359,036
Janumet	Sitagliptin Phos/Metformin Hcl	208	11,005	$193,849
Januvia	Sitagliptin Phosphate	158	9,960	$169,025
Mounjaro	Tirzepatide	98	3,252	$115,173

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	20	81	$33,475
E0784	External ambulatory infusion pump, insulin	Y	N/R	15	$5,374
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	33	78	$1,283
A4259	Lancets, per box of 100	N	15	30	$66
A4256	Normal, low and high calibrator solution / chips	N	N/R	15	$45

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$821	Exact Sciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

Endocrinology providers in the New York-Jersey City-White Plains, NY-NJ market
Providers within practice ZIP code 11222-6577
Providers whose plurality patient county is Kings, NY
Providers in New York affiliated with Community Care of Brooklyn IPA, Inc. (MSSP)

FAQ

What Medicare data is available for Agnieszka Gliwa, MD?

Tedicare shows public-source Medicare data for Agnieszka Gliwa, MD (NPI 1487649919), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Agnieszka Gliwa, MD have ACO affiliation data?

Agnieszka Gliwa, MD is shown with ACO affiliation data for Community Care of Brooklyn IPA, Inc. (MSSP, ACO ID A4723).

What billing organization is linked to Agnieszka Gliwa, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Agnieszka Gliwa, MD have Open Payments data?

Agnieszka Gliwa, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.